IBDEI0ET ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7151,0)
 ;;=V10.52^^55^577^72
 ;;^UTILITY(U,$J,358.3,7151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7151,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,7151,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,7151,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,7152,0)
 ;;=V10.04^^55^577^74
 ;;^UTILITY(U,$J,358.3,7152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7152,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,7152,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,7152,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,7153,0)
 ;;=V10.47^^55^577^75
 ;;^UTILITY(U,$J,358.3,7153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7153,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,7153,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,7153,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,7154,0)
 ;;=V10.83^^55^577^73
 ;;^UTILITY(U,$J,358.3,7154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7154,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,7154,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,7154,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,7155,0)
 ;;=285.22^^55^577^9
 ;;^UTILITY(U,$J,358.3,7155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7155,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,7155,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,7155,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,7156,0)
 ;;=285.21^^55^577^10
 ;;^UTILITY(U,$J,358.3,7156,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7156,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,7156,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,7156,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,7157,0)
 ;;=285.29^^55^577^11
 ;;^UTILITY(U,$J,358.3,7157,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7157,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,7157,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,7157,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,7158,0)
 ;;=284.9^^55^577^12
 ;;^UTILITY(U,$J,358.3,7158,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7158,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,7158,1,5,0)
 ;;=5^Aplastic Anemia NOS
 ;;^UTILITY(U,$J,358.3,7158,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,7159,0)
 ;;=282.61^^55^577^78
 ;;^UTILITY(U,$J,358.3,7159,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7159,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,7159,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,7159,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,7160,0)
 ;;=282.7^^55^577^77
 ;;^UTILITY(U,$J,358.3,7160,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7160,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,7160,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,7160,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,7161,0)
 ;;=283.9^^55^577^79
 ;;^UTILITY(U,$J,358.3,7161,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7161,1,4,0)
 ;;=4^283.9
 ;;^UTILITY(U,$J,358.3,7161,1,5,0)
 ;;=5^Hemolytic Anemia,Acquired
 ;;^UTILITY(U,$J,358.3,7161,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,7162,0)
 ;;=283.0^^55^577^80
 ;;^UTILITY(U,$J,358.3,7162,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7162,1,4,0)
 ;;=4^283.0
 ;;^UTILITY(U,$J,358.3,7162,1,5,0)
 ;;=5^Hemolytic Anemia,Autoimmune
 ;;^UTILITY(U,$J,358.3,7162,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,7163,0)
 ;;=282.9^^55^577^81
 ;;^UTILITY(U,$J,358.3,7163,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7163,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,7163,1,5,0)
 ;;=5^Hemolytic Anemia,Hereditary
 ;;^UTILITY(U,$J,358.3,7163,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,7164,0)
 ;;=283.19^^55^577^82
 ;;^UTILITY(U,$J,358.3,7164,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7164,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,7164,1,5,0)
 ;;=5^Hemolytic Anemia,Microang
